Petro Matad CEO Mike Buck confirmed that he believes the Exploitation Licence for Block XX in Eastern Mongolia is likely to be awarded in Q2. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7,299.00
Bid: 7,299.00
Ask: 7,301.00
Change: 28.00 (0.39%)
Spread: 2.00 (0.03%)
Open: 7,252.00
High: 7,315.00
Low: 7,237.00
Yest. Close: 7,271.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

MARKET COMMENT: UK Stocks Fall As US GDP Surge Turns Attention To Fed

Wed, 30th Jul 2014 16:34

LONDON (Alliance News) - UK stocks had a choppy trading session Wednesday and ultimately closed lower, while the dollar gained against other major currencies, as some heavily anticipated US GDP data showed the world's biggest economy more than reversed its first quarter slump.

The surprisingly strong US economy shifted the market focus squarely onto the Federal Reserve policy announcement still to come Wednesday.

The US economy grew at an annualised rate of 4.0% in the second quarter, more than reversing the 2.1% contraction in the first quarter, which was also revised up from the original 2.9% drop.

The data has been a long time coming for a market hoping for a sharp reversal in US economic growth following the first-quarter contraction, which was broadly blamed on particularly harsh winter weather. However, despite the reading causing an initial surge in global equity markets to session highs, investors have since reverted to caution ahead of a potential change of tone from the Federal Open Market Committee announcement at 1900 BST.

Concern over the potential economic impact of new sanctions from the EU and the US against Russia also have continued to weigh on general sentiment, and particularly the energy sector.

The FTSE 100 closed down 0.5% at 6,773.44 and the FTSE 250 down 0.4% at 15,629.84, while the AIM All-Share outperformed, closing up 0.1% at 772.25.

Within major European markets, the German DAX 30 ended down 0.6% and the French CAC 40 down 1.2%

After the European close, US markets continue to trade mixed, with the DJIA down 0.4%, the S&P 500 down 0.2%, and the Nasdaq Composite up 0.2%.

"The (US) data lends more credence to arguments that the Federal Reserve is nearing its mandates and this may bring forward speculation of when the Fed delivers its first rate hike," said Brown Brothers Harriman's Global Head of Currency Strategy Marc Chandler.

The dollar was the best performing currency in the wake of the bumper US GDP reading. The pound fell to the lowest level in six weeks, bottoming at USD1.6885, while the euro fell to its lowest level in more than eight months, bottoming at USD1.3364.

The UK banking sector provided the main downside support to the FTSE 100 after Barclays followed in Royal Bank of Scotland's recent footsteps by releasing first-half results ahead of analyst expectations.

Barclays said it made a GBP3.35 billion adjusted pretax profit in the first six months of 2014, down from a GBP3.59 billion profit in the year before but ahead of the GBP2.96 billion consensus forecast. Barclays also updated as to its progress on capital ratios, with the CET1 ratio increasing to 9.9% and the PRA leverage ratio increasing to 3.4% in the first half.

"The shares have been terrible performers of late so the profit beat and good progress on capital should come as a welcome relief to the market," said Shore Capital analyst Gary Greenwood.

Barclays ended as the top FTSE 100 gainer, up 4.5%, while RBS closed up 2.8%, and Lloyds, which reports its own results on Thursday, closed up 1.0%.

The bank shares envinced little concern over new Bank of England proposals, unveiled Wednesday, to increase individual responsibility and accountability in the banking sector, with changes including a new approval regime for the most senior bankers and new rules on bonuses.

Travis Perkins gained 2.7% after reporting a rise in pretax profit to GBP153.7 million in the first half, up 14% from the previous year, with the company citing improving market conditions and increased customer confidence. The group's consumer division, which incorporates DIY chain Wickes, saw revenue rise 8.8%.

Pets at Home was the top FTSE 250 gainer, closing up 7.1% after saying like-for-like sales were up 4.1% in the second quarter, boosted by a return to TV advertising and its VIP loyalty scheme. Despite the positive update, which boosted the Pets at Home to 182 pence Wednesday, the stock remains well below its March IPO price of 245p.

Mining stocks weighed on the other end of the market, led lower by Antofagasta, which closed down 4.6% at the bottom of the FTSE 100 after reporting production rates in line with expectations, but also a 16% rise in its net cash costs. Antofagasta has generally underperformed the other copper miners so far this year, which analysts attribute to its significant cost inflation.

Although the new sanctions from the EU and the US on Russia over its hand in the crisis in Ukraine are still short on details, the knowledge that they are on the way kept the energy sector in the red, with Royal Dutch Shell, BG Group, and BP down 1.8%, 1.8%, and 0.5%, respectively.

Given Fed Chair Janet Yellen's insistence that future monetary policy is not on a pre-set course and instead is data-dependent, it would not be unreasonable to expect a shift in the tone of the statement given the bumper US GDP reading just released.

While the statement, which follows the FOMC's two-day meeting, will be closely watched for such a change, it is highly unlikely that the central bank will deviate from the path of tapering asset purchases, and another USD10 billion cut is widely expected, which would leave the Fed on course to finish its quantitative easing programme in October.

Given Yellen's recent comment that US social media stocks are looking stretched, she and her colleagues at the FOMC will no doubt have watched with interest as Twitter jumped another 25% at the opening bell Wednesday, after announcing a huge extension of its user base, which grew by 16 million in the second quarter, adding huge future advertising potential.

Looking towards Thursday, while any unexpected commentary from the Federal Reserve has the potential to provide an early driver for markets, European data will be in focus, with unemployment numbers from across the region due throughout the morning and July eurozone CPI released at 1000 BST.

Another busy day in the UK corporate calendar Thursday brings interim results from Lloyds Banking Group, as well as its recently spun-off retail arm TSB Group. While it's the first update from TSB since its late June flotation, the expectations for Lloyds has been raised by the strong results reported Wednesday and last Friday by peers Barclays and Royal Bank of Scotland.

Drinks giant Diageo is scheduled released full-year results Thursday, while other names with interim results slated include BG Group, Centrica, AstraZeneca, BAE Systems, Rolls-Royce, Weir Group, Countrywide, and Intu Properties.

By Jon Darby;; @jondarby100

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News

Oxford BioMedica annual revenue leaps on AstraZeneca vaccine deal

Oxford BioMedica annual revenue leaps on AstraZeneca vaccine deal

Today 09:00

Germany will take until Q3 to reach COVID-19 group immunity - minister

BERLIN, April 15 (Reuters) - Germany will take until the third quarter to reach group immunity against COVID-19, Health Minister Jens Spahn said on Thursday."It will take until the summer, not at the beginning of July but in the summer in the thir...

Today 08:58

Ireland on track to vaccinate 80% of population by June

Ireland on track to vaccinate 80% of population by June

14 Apr 21 19:43

Greece orders COVID self-testing for service workers

ATHENS, April 14 (Reuters) - Greece will make self-testing for COVID-19 compulsory for service workers in sectors including shops, restaurants and transport, authorities said on Wednesday, as the government looks to gradually reopen the economy.Gr...

14 Apr 21 18:24

Ireland's first dose vaccination target still on track - minister

DUBLIN, April 14 (Reuters) - Ireland's plan for 80% of adults to receive at least one dose of a COVID-19 vaccine by the end of June remains on track after Pfizer Inc-BioNTech announced additional European deliveries on Wednesday, its health minis...

14 Apr 21 17:23

UPDATE 1-Canada will not restrict AstraZeneca COVID-19 vaccine, says benefits outweigh risk

(Adds quote, details)OTTAWA, April 14 (Reuters) - Canada's health ministry said on Wednesday it would not restrict use of AstraZeneca Plc's COVID-19 vaccine after a review showed the benefits outweighed the very rare risk of blood clots.A separate...

14 Apr 21 16:57

LONDON MARKET CLOSE: FTSE ends higher; Goldman up after record quarter

LONDON MARKET CLOSE: FTSE ends higher; Goldman up after record quarter

14 Apr 21 16:55

UPDATE 1-Finland latest to mix COVID-19 vaccines as AstraZeneca crisis delays rollout

(Adds statements by officials, quote on blood clots)HELSINKI, April 14 (Reuters) - Finland said on Wednesday people aged under 65 who got a first dose of the AstraZeneca COVID-19 shot may get a different vaccine for their second dose, as authoriti...

14 Apr 21 16:21

Canada says it won't restrict use of AstraZeneca COVID-19 vaccine at this time

OTTAWA, April 14 (Reuters) - Canada's health ministry said on Wednesday it would not restrict use of AstraZeneca PLC's COVID-19 vaccine at this time after a review showed the benefits outweighed the very rare risk of blood clots.A separate advisor...

14 Apr 21 16:10

Italy suspends distribution of J&J shots after use paused in U.S.

ROME, April 14 (Reuters) - Italy said on Wednesday it had suspended the use of some 184,000 shots of the Johnson & Johnson COVID-19 vaccine, after the brand delayed its introduction in Europe following a health scare in the United States.The firs...

14 Apr 21 15:50

Italians seen increasingly reluctant to accept AstraZeneca shots

By Crispian BalmerROME, April 14 (Reuters) - The head of healthcare management in Italy's largest region, Lombardy, said on Wednesday there was a growing reluctance amongst residents to accept AstraZeneca's COVID-19 vaccine because of safety fears...

14 Apr 21 15:41

AstraZeneca says respects Denmark's decision to stop using its vaccine

FRANKFURT, April 14 (Reuters) - AstraZeneca said on Wednesday it respected the decision of Danish health regulators to stop using the company's COVID-19 vaccine altogether because of a possible link to cases of a very rare type of blood clot."We r...

14 Apr 21 15:23

Denmark scraps use of AstraZeneca vaccine

(Sharecast News) - Denmark has stopped using AstraZeneca's vaccine in its Covid-19 inoculation programme because of concerns about cases of rare blood clots.

14 Apr 21 15:08

UPDATE 2-South Africa says non-refundable downpayments among onerous vaccine terms

* Country has signed big vaccine deals with J&J, Pfizer* Minister says manufacturers made difficult demands* Paused J&J rollout on Tuesday over U.S. blood clot reports* Minister signals pause may be short-lived (Adds quotes, detail, SAHPRA)By Wendel...

14 Apr 21 14:43

UPDATE 1-EU vaccination drive could slip by over 2 months without J&J - Airfinity

(Adds context on delay; AstraZeneca restrictions)By Douglas BusvineBERLIN, April 14 (Reuters) - The suspension of Johnson & Johnson's coronavirus vaccine could delay efforts to inoculate most people in the European Union by over two months, scient...

14 Apr 21 14:20

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.